PLX
Protalix Biotherapeutics Inc
2.80$
-1.4%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | -186.5% | – | – | -4,927.2% | – | – | – | – | – | – | – | – | – | – | – | -238.3% | |
| – | – | – | -19.3% | – | – | – | – | – | – | – | +51.2% | +71.4% | +53.0% | +57.4% | +15.9% | +1.7% | -4.1% | -11.3% | -24.5% | -16.3% | -3.2% | -13.0% | -3.2% | -19.5% | -14.1% | -2.9% | +9.7% | +9.5% | +12.3% | |
| – | – | – | – | – | – | – | – | – | – | – | +217.0% | -71.7% | -12.6% | -52.2% | -30.9% | +774.8% | -47.2% | -69.6% | +45.1% | -45.2% | -65.9% | +52.5% | +62.5% | +274.4% | -24.0% | -12.2% | +65.4% | -5.7% | -29.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +420.5% | -78.0% | -53.9% | +642.8% | -284.5% | – | -98.8% | +67.7% | +232.3% | +29.9% | -84.6% | – | – | – | |
| – | -87.2% | +5,389.7% | -292.7% | – | -303.3% | – | -106.6% | – | – | +10,852.8% | +287.7% | +92.8% | +3,439.1% | -119.2% | – | -90.7% | -1,516.5% | – | – | – | +2,505.5% | -53.5% | -150.5% | – | – | -221.4% | – | – | -1,345.3% | |
| – | – | – | -79.1% | -100.0% | – | – | – | – | – | – | +177.3% | +44.4% | +83.8% | +26.8% | -27.4% | -63.8% | -8.6% | -58.5% | -40.9% | +83.0% | +14.4% | -29.4% | -8.6% | +4.5% | +122.7% | -57.0% | +83.0% | +11.6% | +27.8% | |
| – | – | -12,179.8% | – | -86.6% | +1,741.5% | -97.1% | -1,373.6% | – | – | – | +148.8% | +51.8% | +66.8% | +29.4% | -26.6% | -61.0% | -8.0% | -52.4% | – | -102.5% | +15.7% | -47.2% | +49.4% | +2,159.6% | – | -126.6% | +231.9% | – | -156.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +23.3% | -99.6% | -58.9% | +1,060.9% | -97.4% | -100.0% | – | – | – | -1.0% | -82.2% | +199.4% | -85.3% | +157.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -70.5% | +0.0% | +0.0% | -107.2% | +234.9% | -95.5% | +0.0% | +15,770.7% | -100.0% | – | – | -100.0% | |
| – | – | – | -100.1% | +455.2% | – | – | – | – | – | +3,282.2% | +250.5% | -100.1% | – | +71.0% | +4,077.0% | +26.9% | +151.9% | -99.9% | +14,323.9% | +196.8% | -107.2% | +234.9% | – | +0.0% | -74.0% | -31.8% | +199.4% | -168.1% | – | |
| – | -131.4% | – | -173.2% | – | – | -120.6% | – | – | +9.7% | +2,423.5% | +336.5% | -141.4% | – | -217.3% | – | – | +37.3% | -192.0% | – | -160.6% | – | – | – | – | +4,280.5% | -205.6% | – | -159.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | -221.1% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -284.4% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.